StonvexLoading…
StonvexStonvexStonvexCore line items from AEYE's most recent SEC filings (10-K / 10-Q via EDGAR XBRL). Last 4 reporting periods.
| Metric | Annual 2025 2025-12-31 | Annual 2024 2024-12-31 | Annual 2023 2023-12-31 | Annual 2022 2022-12-31 |
|---|---|---|---|---|
Revenue | $40.31M | $35.20M | $31.32M | $29.91M |
Operating Income | $-1.83M | $-3.39M | $-5.96M | $-10.43M |
Net Income | $-3.08M | $-4.25M | $-5.87M | $-10.43M |
EPS (Diluted) | $-0.25 | $-0.36 | $-0.50 | $-0.91 |
Total Assets | $32.23M | $29.77M | $25.50M | $24.43M |
Total Liabilities | $27.43M | $20.33M | $18.79M | $13.84M |
Cash & Equivalents | $5.29M | $5.65M | $9.24M | $6.90M |
Free Cash Flow OCF − CapEx | $4.70M | $2.60M | $147.00K | $-5.07M |
Shares Outstanding | 12.38M | 12.29M | 11.71M | 11.55M |